EGFR and non-small cell lung carcinoma: In previous studies, we had generated a panel of 18 EGFR TKI resistant clones from the EGFR-mut, non-small cell lung cancer (NSCLC) lines PC9 and 11–18 (Table S5, Fig. S1A).